Skip to main content

Statute

BPCIA

102 published works

  1. Biosimilars Law Blog

    FDA Anticipates New Draft Biosimilar Guidances

    By Marie A. Vodicka

    Including biosimilars in the release of expected 2014 CDER draft guidance documents has sparked the public interest as industry, physicians, patients and others await additional cues on FDA’s implementation of…

  2. Biosimilars Law Blog

    Universities urge FDA to require certification of information exchange for biosimilar applications

    By Marie A. Vodicka

    A collection of associations for higher education wrote to FDA Commissioner Margaret Hamburg urging a requirement for biosimilar applicants to certify that they have complied with the information exchange and…